0001127602-12-027241.txt : 20120927
0001127602-12-027241.hdr.sgml : 20120927
20120927180751
ACCESSION NUMBER: 0001127602-12-027241
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120926
FILED AS OF DATE: 20120927
DATE AS OF CHANGE: 20120927
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Trevor M
CENTRAL INDEX KEY: 0001298861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10269
FILM NUMBER: 121114123
MAIL ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLERGAN INC
CENTRAL INDEX KEY: 0000850693
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 951622442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 7142464500
MAIL ADDRESS:
STREET 1: P.O. BOX 19534
CITY: IRVINE
STATE: CA
ZIP: 92713-9534
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-09-26
0000850693
ALLERGAN INC
AGN
0001298861
Jones Trevor M
2525 DUPONT DRIVE
IRVINE
CA
92612
1
Common Stock
2012-09-26
4
S
0
1500
91.92
D
17327
D
Common Stock
2012-09-26
4
M
0
1000
60.60
A
18327
D
Common Stock
2012-09-26
4
S
0
1000
91.92
D
17327
D
Nonemployee Director Stock Option (Right to Buy)
60.60
2012-09-26
4
M
0
1000
0
D
2017-05-01
Common Stock
1000
7400
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 10, 2012.
Includes 4,800 shares of the Issuer's common stock underlying the RSUs awarded.
Includes shares issued pursuant to the dividend equivalent rights, exempt transaction under Rule 16a-11.
Option is fully vested and exercisable on the date of the next regular annual meeting of stockholders of Allergan, Inc. at which directors are to be elected following the date of grant.
/s/ Matthew J. Maletta, Attorney-in-Fact for Trevor M. Jones
2012-09-27